Summary for Patent: 6,977,042

Title:

Microstructured filter

Abstract:

A microstructured filter having an inlet for unfiltered fluid; an outlet for filtered fluid; a plurality of projections which are arranged in at least two rows in mutually juxtaposed relationship, project out of a base plate and are an integral component of the base plate; a plurality of passages between the projections and a cover plate which is securable to the base plate to cover the projections and the passages. The passages form a plurality of through paths from the inlet to the outlet. The inlet includes an elongate inlet slot for the unfiltered fluid that extends over approximately the entire filter width and is approximately as high as the projection on the outlet side of the filter.

Foreign Priority and PCT Information for Patent: 6,977,042

Non-Orange Book Patents for Patent: 6,977,042

For Orange Book-listed
patents (shown in the main table above) generic applications
must certify that the listed patents are expired, invalid, or
will not be infringed by generic entry.

The non-Orange Book patents listed
below do not require formal certifications, so they do not
automatically impede generic entry. Instead, they represent
potential opportunities for branded firms to block generic
entry through patent infringment challenges.

This preview shows a limited data setSubscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

International Patent Family for Patent: 6,977,042

This preview shows a limited data setSubscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.

How are People Using DrugPatentWatch?

To know patent expirations 8-15 years from now and formulation information

— Generic drug importer, Japan

To explore which pharmaceutical products are still under patent protection

— Managing partner for pharmaceutical company, Lebanon

To have a global perspective of drug product patents

— Generic drug product company R&D manager, Spain

To watch the expiration date of patents on some of the drugs we work with

— Pharmaceutical researcher, Russia

To find drug patent expiry dates in Europe

— Analyst, Switzerland

To gain knowledge on formulations of different drugs

— Product development officer, Pharmaceutical company, Bangladesh

To research drug patent expirations and NCE dates

— Patent attorney, USA

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.